DK174026B1 - 4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser - Google Patents

4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser Download PDF

Info

Publication number
DK174026B1
DK174026B1 DK198603154A DK315486A DK174026B1 DK 174026 B1 DK174026 B1 DK 174026B1 DK 198603154 A DK198603154 A DK 198603154A DK 315486 A DK315486 A DK 315486A DK 174026 B1 DK174026 B1 DK 174026B1
Authority
DK
Denmark
Prior art keywords
methyl
alkyl
pyridine
substituted
nitrophenyl
Prior art date
Application number
DK198603154A
Other languages
Danish (da)
English (en)
Other versions
DK315486D0 (da
DK315486A (da
Inventor
Yoshiharu Hiramatsu
Masaru Kawakami
Motohiko Ueda
Ikuo Adachi
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK315486D0 publication Critical patent/DK315486D0/da
Publication of DK315486A publication Critical patent/DK315486A/da
Application granted granted Critical
Publication of DK174026B1 publication Critical patent/DK174026B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198603154A 1985-07-03 1986-07-02 4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser DK174026B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14705485 1985-07-03
JP60147054A JPS6210087A (ja) 1985-07-03 1985-07-03 4,7−ジヒドロチエノ〔2,3−b〕ピリジン誘導体,その製造法および循環器系疾患治療剤

Publications (3)

Publication Number Publication Date
DK315486D0 DK315486D0 (da) 1986-07-02
DK315486A DK315486A (da) 1987-01-04
DK174026B1 true DK174026B1 (da) 2002-04-29

Family

ID=15421457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198603154A DK174026B1 (da) 1985-07-03 1986-07-02 4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser

Country Status (7)

Country Link
US (1) US4703051A (ko)
EP (1) EP0207345B1 (ko)
JP (1) JPS6210087A (ko)
KR (1) KR930005175B1 (ko)
DE (1) DE3683549D1 (ko)
DK (1) DK174026B1 (ko)
GB (1) GB2177400B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4874760A (en) * 1987-01-09 1989-10-17 Toa Eiyo, Ltd. 4,7-dihydroisothiazolo(5,4-b)pyridine derivatives and cardiovascular treating agents containing said derivatives
GB8801491D0 (en) * 1988-01-22 1988-02-24 Beecham Group Plc Novel compounds
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
DE69101594T2 (de) * 1990-07-04 1994-07-21 Shionogi Seiyaku Kk Verfahren zur Herstellung einer nichtkohäsiven Überzugsschicht.
JP2632754B2 (ja) * 1991-05-21 1997-07-23 塩野義製薬株式会社 脳内グルタミン酸遊離抑制剤
US6037340A (en) * 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
JP3046589U (ja) * 1997-08-26 1998-03-10 株式会社三栄マシニング モンキ−スパナ−
ZA200605471B (en) * 2003-12-23 2007-11-28 Dow Agrosciences Llc Process for the preparation of pyridine derivatives
JP2007230869A (ja) * 2004-04-05 2007-09-13 Takeda Chem Ind Ltd アルドステロン受容体拮抗剤
JP2009520833A (ja) * 2005-12-20 2009-05-28 ギリード・コロラド・インコーポレーテッド 4,7−ジヒドロチエノ[2,3−b]ピリジン化合物及び医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310746A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DD210278A5 (de) * 1982-03-05 1984-06-06 Boehringer Ingelheim Kg Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd 4,7−ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
EP0207345A2 (en) 1987-01-07
DK315486D0 (da) 1986-07-02
JPH0556358B2 (ko) 1993-08-19
US4703051A (en) 1987-10-27
GB2177400B (en) 1989-04-05
KR930005175B1 (ko) 1993-06-16
DK315486A (da) 1987-01-04
EP0207345B1 (en) 1992-01-22
GB2177400A (en) 1987-01-21
JPS6210087A (ja) 1987-01-19
EP0207345A3 (en) 1988-02-24
GB8616238D0 (en) 1986-08-13
DE3683549D1 (de) 1992-03-05
KR870001214A (ko) 1987-03-12

Similar Documents

Publication Publication Date Title
US9862702B2 (en) Processes for the preparation of pesticidal compounds
TWI402263B (zh) 化合物
DK174026B1 (da) 4,7-dihydrothieno[2,3-b]pyridinderivater, fremgangsmåde til fremstilling deraf samt præparater indeholdende disse forbindelser
JP6117999B2 (ja) テトラヒドロシクロペンタピロール誘導体およびその製造方法
AU2020250183A1 (en) Aryl cyclopropyl-amino-isoquinolinyl amide compounds
EP1107973B1 (en) NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
CZ2001503A3 (cs) Deriváty 1H-imidazopyridinu
IL132763A (en) Theo [[2,3 – d] pyrimidine - 2, 4 (H1, H3) Diones - transformed at position 6, processes for their preparation, the compositions containing them and their use in healing
US20090036443A1 (en) Thienopyrroles as antiviral agents
JP2008503531A (ja) ピリダジン−3(2h)−オン誘導体およびpde4の阻害剤としてのそれらの使用
NO333586B1 (no) Krystallinsk clopidogrel og fremgangsmate for fremstilling derav
WO2008076562A1 (en) 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
CZ327698A3 (cs) Aminoisochinolinový a aminothienopyridinový derivát a jejich použití jako protizánětlivých přípravků
JP2012072067A (ja) 含窒素芳香族へテロ環化合物
JPH08337583A (ja) 複素環化合物およびその製造法
US5149702A (en) Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
CA1269661A (en) Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
JPS61115082A (ja) 三環式ピリジン誘導体
EP0822194A1 (en) FUSED IMIDAZO 1,2-a]PYRIDINES
DK2611444T3 (en) Heterocyclyl compounds as histamine H3 receptor ligands
WO2009060030A1 (en) Heteroaryl-substituted 2-pyridinylmethylamine derivatives
US6258829B1 (en) Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
WO2009095752A1 (en) Fused pyrazole derivatives as cannabinoid receptor modulators
CZ177892A3 (en) AMINOMETHYL SUBSTITUTED 2,3-DIHYDROPYRAN(2,3-b)PYRIDINES, PROCESS OF THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
US5621103A (en) Tetrahydropyridine derivative having substituents on three rings

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK